Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Variance of HRD From Primary to Recurrent in High-grade Serous Ovarian Cancer

NCT05069818 is registered in ClinicalTrials.gov with Xiaoxiang Chen as lead sponsor.

NCT NCT05069818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05069818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Variance of HRD From Primary to Recurrent in High-grade Serous Ovarian Cancer
Lead sponsor
Xiaoxiang Chen
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2021
Completion date
December 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hrd, ovarian cancer, platinum-sensitive ovarian cancer